Location of Repository

Development and Evaluation of a Rapid Molecular Assay and a Mask Sampling Method Enabling the Study of Tuberculosis Transmission

By Eddy Seong Guan Cheah

Abstract

Mycobacterium tuberculosis (Mtb) is transmitted in small aerosol droplets expectorated by individuals with active pulmonary tuberculosis (TB). There is still no established method for sampling these infectious aerosols and measuring the bacterial concentration in them. Little is known about the relationship between tuberculous aerosol output and infectiousness of TB cases; medical practice currently relies on the acid-fast smear status to gauge this and determine when it is safe to discharge TB patients. This study involved the development and evaluation of a rapid molecular assay and a mask sampling approach to increase our knowledge relating to TB transmission. A molecular assay targeting the mycobacterial 16S rDNA and differentiating Mtb complex from non-tuberculous mycobacteria was developed to facilitate recruitment of TB patients for the mask sampling study. Although the assay did not achieve this outcome during the study, we demonstrated its clinical utility on mycobacterial isolates. A second molecular assay targeting the Mtb global lineagedefining and locally prevalent RD750 polymorphism was also developed for preliminary genotyping of Mtb strains to assess for potential recent transmission events. Both the 16S and RD assays were performed in single thermocycler runs but in separate reaction tubes and utilised a combination of TaqMan and SYBR Green technologies to simultaneously differentiate two products. The 16S-RD assay shows promising potential for direct specimen analysis and detection of mixed infections. A novel method of mask aerosol sampling coupled to a mycobacteriophage amplification assay developed in this study was able to detect and to some extent quantify the amount of respiratory-borne Mtb. This approach could potentially be more reliable than smear microscopy in assessing TB infectivity. With further optimisation and improvement, both the 16S-RD assay and the mask sampling method have potential to facilitate better understanding of TB transmission and subsequently contribute to public and clinical management of this disease

Publisher: University of Leicester
Year: 2010
OAI identifier: oai:lra.le.ac.uk:2381/9081

Suggested articles

Preview

Citations

  1. (1992). 143:372–377 2. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the Br Thoracic Society. Thorax
  2. (1998). A bacterial cytokine.
  3. a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis.
  4. (2006). A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.
  5. (2007). A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci USA 2006, 103: 15. The Diversity of Leicester: A Demographic Profile. Edited by Leicester City Council,
  6. (1959). A factor in serum albumin which prevents the inhibition of propagation of D-29 mycobacteriophage by Tween.
  7. (2002). A family of autocrine growth factors in Mycobacterium tuberculosis.
  8. (2000). A high yielding mutant of mycobacteriophage L1 and its application as a diagnostic tool.
  9. (1994). A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples.
  10. (2002). A new evolutionary scenario for the Mycobacterium tuberculosis complex.
  11. (2008). A new method for sampling and detection of exhaled respiratory virus aerosols.
  12. (2006). A peptidoglycan hydrolase motif within the mycobacteriophage TM4 tape measure protein promotes efficient infection of stationary phase cells.
  13. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
  14. (1984). Abortive infection of Mycobacterium leprae by the mycobacteriophage D29.
  15. (2005). Adding value to the analysis of acid-fast bacillus smear-positive respiratory specimens by real-time PCR analysis. M.Sc. thesis.
  16. (2009). Address reprint requests to
  17. (1959). Aerial dissemination of pulmonary tuberculosis: a twoyear study of contagion in a tuberculosis ward.
  18. (1957). Air hygiene in tuberculosis: quantitative studies of infectivity and control in a pilot ward.
  19. (1974). Airborne infection.
  20. (1978). Airborne spread of measles in a suburban elementary school.
  21. (2000). An analysis of some hypotheses related to the Chingelput bacille Calmette-Guerin trial.
  22. (2002). An expanded DOTS framework for effective tuberculosis control.
  23. (2005). An extremely rapid and simple DNA-release method for detection of M. tuberculosis from clinical specimens.
  24. (2001). An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes.
  25. (2007). An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
  26. (1998). An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis.
  27. (1992). An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer.
  28. (1986). An outbreak of tuberculosis in a children's hospital.
  29. (1992). An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms.
  30. (2005). Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis.
  31. (2006). Animation of technique.
  32. (1959). Anonymous mycobacteria in pulmonary disease.
  33. (2004). Antibiotic resistance may affect alkali decontamination of specimens containing mycobacteria.
  34. (1996). Are healthcare workers in England and Wales at increased risk of tuberculosis?
  35. (2009). ATPase genes of diverse multidrug-resistant Acinetobacter baumannii isolates frequently harbour integrated DNA.
  36. (1991). Audit of tuberculosis contact tracing procedures in South Gwent.
  37. (2010). Available from: http://www.mspcorp.com/aero_products.php [cited 5
  38. (1997). Bacterial survival on respirator filters and surgical masks.
  39. (1954). Bacteriophage active against virulent Mycobacterium tuberculosis. I. Isolation and activity.
  40. (2005). Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis.
  41. (1978). Benjamin Marten and his "New Theory of Consumptions".
  42. (2005). Bioaerosol mass spectrometry for rapid detection of individual airborne Mycobacterium tuberculosis H37Ra particles.
  43. (2002). Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease.
  44. (2008). Chapter 4: Mask Detection Methods Chapter 6: General Discussion
  45. (2007). Characterising the mobile genome of Shigella.
  46. (1998). Characterization and targeted disruption of a glycosyltransferase gene in the tylosin producer, Streptomyces fradiae.
  47. (1990). Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.
  48. (2008). Characterization of temperate phage Che12 and construction of a new tool for diagnosis of tuberculosis.
  49. (1998). Chemotherapy and management of tuberculosis in the United Kingdom: recommendations
  50. (1990). Collection and characteristics of mycobacteria in aerosols.
  51. (2006). Color atlas and textbook of diagnostic microbiology. 6th edition.
  52. Colorimetric phage-based assay for detection of rifampicin resistant Mycobacterium tuberculosis.
  53. (1996). Community-based outbreaks of tuberculosis.
  54. (2001). Comparing genomes within the species Mycobacterium tuberculosis.
  55. (1997). Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection.
  56. (2001). Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.
  57. (2005). Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR.
  58. (2003). Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.
  59. (1982). Comparison of the pour, spread, and drop plate methods for enumeration of Rhizobium spp. in inoculants made from presterilized peat.
  60. (2001). Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence.
  61. (1997). Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis.
  62. (2008). Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.
  63. (1975). Contacts of cases of active pulmonary tuberculosis.
  64. Continuing Mycobacterium bovis transmission from animals to humans in New Zealand.
  65. (2000). Control and prevention of tuberculosis in the United Kingdom: code of practice
  66. (1969). Cough frequency and infectivity in patients with pulmonary tuberculosis.
  67. (2004). Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness.
  68. (2004). Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.
  69. (1978). Current status of the problem. I. Epidemiology of tuberculosis.
  70. (2008). Cytological and transcript analyses reveal fat and lazy persisterlike bacilli in tuberculous sputum.
  71. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
  72. (2005). Design of primers.
  73. (1999). Detection and characterization of airborne Mycobacterium tuberculosis H37Ra particles, a surrogate for airborne pathogenic M. tuberculosis.
  74. (2003). Detection and differentiation of Mycobacterium tuberculosis and nontuberculous mycobacterial isolates by real-time PCR.
  75. (2008). Detection and molecular characterization of 9,000-yearold Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean.
  76. (2004). Detection of Mycobacterium tuberculosis complex by PCR in hospital air samples.
  77. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction.
  78. (1994). Detection of varicella-zoster virus DNA in air samples from hospital rooms.
  79. (2003). Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA.
  80. (2007). Development of a new rapid combined phage and PCR method for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours.
  81. (2007). Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis.
  82. (2008). Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients.
  83. (2007). Diagnostic potential of IS6110, 38kDa, 65kDa and 85B sequence-based polymerase chain reaction in the diagnosis of Mycobacterium tuberculosis in clinical samples.
  84. (2000). Diagnostic standards and classification of tuberculosis in adults and children
  85. (1993). Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory by polymerase chain reaction.
  86. (1994). Dormancy of Mycobacterium tuberculosis and latency of disease.
  87. (1967). Droplet expulsion from the respiratory tract.
  88. (1964). Effect of temperature on the bacteriophage susceptibility of strains of Mycobacterium avium isolated from fowl.
  89. (1958). Effect of Tween 80 and serum on the interaction of mycobacteriophage D-29 with certain mycobacterial species.
  90. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature.
  91. (2003). Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov.
  92. (1985). Epidemiology of a tuberculosis outbreak in a South Carolina junior high school.
  93. (1962). Epidemiology of an outbreak of tuberculosis among school children.
  94. (1996). Epidemiology of infection by nontuberculous mycobacteria.
  95. (1965). Epidemiology of primary tuberculosis in an industrial school.
  96. (2002). Ethnic-specific genetic associations with pulmonary tuberculosis.
  97. (1997). Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis.
  98. (2003). Evaluation of FASTPlaqueTB-RIFTM for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
  99. (1994). Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols.
  100. (2003). Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry.
  101. (1999). Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.
  102. (1993). Exogenous reinfection with multidrugresistant Mycobacterium tuberculosis in patients with advanced HIV infection.
  103. (2002). Expression of mycobacteriophage Ms6 lysis genes is driven by two sigma (70)-like promoters and is dependent on a transcription termination signal present in the leader RNA.
  104. (1990). Extrapulmonary tuberculosis in the United States. American Review of Respiratory Disease,
  105. (2002). Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.
  106. (2004). FASTPlaqueTB: a rapid bacteriophage assay for the detection of Mycobacterium tuberculosis complex in clinical samples. Product Insert. Ipswich: Biotec Laboratories.
  107. (1990). Formamide can dramatically improve the specificity of PCR.
  108. (2004). Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains.
  109. (1998). Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats.
  110. (2007). Genome analysis shows a common evolutionary origin for the dominant strains of Mycobacterium tuberculosis in a UK South Asian community.
  111. (1998). Genome structure of mycobacteriophage D29: implications for phage evolution.
  112. (2002). Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex.
  113. (2007). Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development.
  114. (2009). Global tuberculosis control: a short update to the 2009 report.
  115. (1962). Growth characteristics of mycobacteriophages D28 and D29.
  116. (2010). Growth, cell division and sporulation in mycobacteria.
  117. (2004). Health impacts of environmental mycobacteria.
  118. (2004). High-throughput method for detecting genomic-deletion polymorphisms.
  119. (1996). History of the sanatorium movement.
  120. (1992). Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients.
  121. (1996). How contagious is tuberculosis?
  122. (1999). How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
  123. (1999). Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.
  124. (1983). Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types.
  125. (2001). Images are properties of Kimberly-Clark Worldwide,
  126. (2007). Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis.
  127. (1998). Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis
  128. (2002). Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom.
  129. (1995). Infectiousness of a university student with laryngeal and cavitary tuberculosis.
  130. (1962). Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients.
  131. (1946). Infectiousness of the "closed case" in tuberculosis.
  132. (1973). Infectiousness of tuberculosis patients.
  133. (1954). Infectivity of pulmonary tuberculosis in relation to sputum status.
  134. (1999). Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.
  135. (2009). Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
  136. (2001). Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis.
  137. intracellulare in sputum samples.
  138. (2004). Investigation of laboratory cross-contamination of Mycobacterium tuberculosis cultures.
  139. (1998). IS6110 transposition and evolutionary scenario of the direct repeat locus in a group of closely related Mycobacterium tuberculosis strains.
  140. (2008). IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species.
  141. (1998). Isolation of genomic DNA from mycobacteria.
  142. (1995). L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria.
  143. (2003). Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection.
  144. (1999). Learning from the genome sequence of Mycobacterium tuberculosis H37Rv.
  145. (1982). Lipids: complex lipids, their chemistry, biosynthesis and roles.
  146. (2003). Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis
  147. (2000). Loop-mediated isothermal amplification of DNA.
  148. (2007). Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in
  149. (2001). Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.
  150. (1939). Marital tuberculosis: a study of 210 couples in which both husband and wife have clinical tuberculosis.
  151. (1999). Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
  152. (1998). Mechanisms of latency in Mycobacterium tuberculosis.
  153. (1997). Metalworking fluid-associated hypersensitivity pneumonitis: a workshop summary.
  154. (2002). Microarrays for public health: genomic epidemiology of tuberculosis.
  155. (1992). Mixed bronchial infection due to Mycobacterium tuberculosis and Mycobacterium avium-intracellulare in an AIDS patient.
  156. (2003). MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.
  157. (2003). Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis.
  158. (2005). Molecular analysis of the lower respiratory tract microbiota.
  159. (1998). Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy.
  160. (1999). Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through
  161. (1994). Molecular epidemiology of tuberculosis.
  162. (1997). Molecular evidence for tuberculosis in an ancient Egyptian mummy.
  163. (2006). Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation.
  164. (1987). Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects.
  165. (1994). Mycobacterial cell wall: structure and role in natural resistance to antibiotics.
  166. (1994). Mycobacterial taxonomy.
  167. (1997). Mycobacteriophage L5 infection of Mycobacterium bovis BCG: implications for phage genetics in the slow-growing mycobacteria.
  168. (2009). Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase.
  169. (2005). Mycobacteriophages and tuberculosis.
  170. (2006). Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.
  171. (1993). Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1-seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire.
  172. (2009). Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis.
  173. (1993). Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis: application for strain differentiation by a novel typing method.
  174. (1987). Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood.
  175. (1994). New pyruvylated, glycosylated acyltrehaloses from Mycobacterium smegmatis strains, and their implications for phage resistance in mycobacteria.
  176. (1958). New sampler for the collection, sizing, and enumeration of viable airborne particles.
  177. (2005). NOA antimicrobial supplement. Product Insert. Ipswich: Biotec Laboratories.
  178. (1989). Nosocomial epidemic of active tuberculosis among HIV-infected patients.
  179. (1990). Nosocomial transmission of tuberculosis associated with a draining abscess.
  180. (1982). Nosocomial tuberculosis.
  181. (2002). Occurrence of mycobacteria in water treatment lines and in water distribution systems.
  182. (1934). On air-borne infection: droplets and droplet nuclei.
  183. (1998). On resuscitation from the dormant state of Micrococcus luteus.
  184. (2007). Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.
  185. (2005). Operational note to profession: changes to the BCG vaccination programme in England. London: Department of Health.
  186. (1996). Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
  187. (1995). Outbreak of tuberculosis among regular patrons of a neighborhood bar.
  188. (2000). Parallel faecal and organ Mycobacterium avium subsp. paratuberculosis culture of different productivity types of cattle.
  189. (1997). Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis.
  190. (2004). Patients with active tuberculosis often have different strains in the same sputum specimen.
  191. (2003). PCR protocols.
  192. (2002). Performance of a rapid phage-based test, FASTPlaqueTBTM, to diagnose pulmonary tuberculosis from sputum specimens in South Africa.
  193. (1991). Permeability of the mycobacterial cell wall.
  194. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS.
  195. (2004). Polymerase chain reaction used for the detection of airborne Mycobacterium tuberculosis in health care settings.
  196. (1995). Pre-Columbian tuberculosis in northern Chile: molecular and skeletal evidence.
  197. (2006). Predominance of ancestral lineages of Mycobacterium tuberculosis in India. Emerging Infectious Diseases,
  198. (1993). Primary cutaneous tuberculosis after a needlestick injury from a patient with AIDS and undiagnosed tuberculosis.
  199. (2008). Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia.
  200. (1997). Pulmonary illness associated with exposure to Mycobacterium avium complex in hot tub water: hypersensitivity pneumonitis or infection?
  201. (2005). Quantification of airborne Mycobacterium tuberculosis in health care setting using real-time qPCR coupled to an air-sampling filter method.
  202. (1967). Quantitative studies of mycobacterial populations in sputum and saliva.
  203. (2002). Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene.
  204. (2002). Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR.
  205. (1993). Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.
  206. (2003). Rapid detection and determination of the aerodynamic size range of airborne mycobacteria associated with whirlpools.
  207. (1999). Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box.
  208. (2002). Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTBRIFTM, a manual phage-based test.
  209. (2006). Real-time PCR.
  210. (2008). Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis.
  211. (1995). Respiratory protection and the risk of Mycobacterium tuberculosis infection.
  212. (1997). Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.
  213. (2010). Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum.
  214. (2000). Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment.
  215. (2007). Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis.
  216. (1998). Sampling and analytical method development for qualitative assessment of airborne mycobacterial species of the Mycobacterium tuberculosis complex.
  217. (1994). Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories.
  218. (2004). Simultaneous infection with multiple strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis.
  219. (2006). Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites.
  220. (2007). Specific electrochemical phage sensing for Bacillus cereus and Mycobacterium smegmatis.
  221. (1997). Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone.
  222. (2000). Spoligotyping and polymorphic GC-rich repetitive sequence fingerprinting of Mycobacterium tuberculosis strains having few copies of IS6110.
  223. (1963). Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria.
  224. (2004). Stable association between strains of Mycobacterium tuberculosis and their human host populations.
  225. (2001). Standard face masks.
  226. (1975). Stimulation of proteinase K action by denaturing agents: application to the isolation of nucleic acids and the degradation of 'masked' proteins.
  227. (2003). Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.
  228. (1996). Substances interfering with direct detection of Mycobacterium tuberculosis in clinical specimens by PCR: effects of bovine serum albumin.
  229. (1993). Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria.
  230. (1999). Survival of bacteria on respirator filters.
  231. (2010). synergistically to the virulence of Pseudomonas aeruginosa strain PA14. Infection and Immunity,
  232. (2008). Tape measure protein having MT3 motif facilitates phage entry into stationary phase cells of Mycobacterium tuberculosis.
  233. (1996). TB/HIV: a clinical manual. Romano Canavese: Stabilimento Tipografico Ferrero.
  234. (2001). Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.
  235. (1952). The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man.
  236. (1968). The Byrd study: in-depth analysis of a micro-outbreak of tuberculosis in a closed environment.
  237. (2007). The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery.
  238. (2006). The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse.
  239. (1999). The detection of airborne Mycobacterium tuberculosis using micropore membrane air sampling and polymerase chain reaction.
  240. (2007). The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model.
  241. (2008). The diversity of Leicester: a demographic profile.
  242. (1990). The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria.
  243. (1980). The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
  244. (1998). The early history of tuberculosis in central East Africa: insights from the clinical records of the first twenty years of Mengo Hospital and review of relevant literature.
  245. (1995). The envelope of mycobacteria.
  246. (1994). The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods.
  247. (2001). The evolution of mycobacterial pathogenicity: clues from comparative genomics.
  248. (2006). The history of tuberculosis.
  249. (1993). The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.
  250. (2001). The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clinical Infectious Diseases,
  251. (2005). The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi.
  252. (2008). The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis.
  253. (2002). The methyl-branched fortifications of Mycobacterium tuberculosis.
  254. The nature and the mode of propagation of phthisis.
  255. (1997). The origin and erratic global spread of tuberculosis: how the past explains the present and is the key to the future.
  256. (2000). The origins and precolonial epidemiology of tuberculosis in the Americas: can we figure them out?
  257. (1974). The prognosis of a positive tuberculin reaction in childhood and adolescence.
  258. (2008). The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro.
  259. (2007). The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data.
  260. (2005). The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes.
  261. (2003). The transmission of tuberculosis in confined spaces: an analytical review of alternative epidemiological models.
  262. (1998). The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria. In Mycobacteria protocols.
  263. (1984). The usefulness of phage typing Mycobacterium tuberculosis isolates.
  264. (1993). Transmission of HIVassociated tuberculosis to healthcare workers.
  265. (1996). Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight.
  266. (1999). Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.
  267. (2001). Transmission of Mycobacterium tuberculosis through casual contact with an infectious case.
  268. (1976). Transmission of tubercle bacilli: the effects of chemotherapy.
  269. (1994). Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods.
  270. Treatment of tuberculosis guidelines. 4th edition.
  271. (1999). Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene.
  272. (1992). Tuberculosis contact tracing: are the British Thoracic Society guidelines still appropriate?
  273. (1960). Tuberculosis disseminators: a study of the variability of aerial infectivity of tuberculous patients.
  274. (1989). Tuberculosis epidemic among hospital personnel. Infection Control and Hospital Epidemiology,
  275. (1996). Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade.
  276. (2003). Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp.
  277. (1943). Tuberculosis in the household: its occurences in marital partners and other members of the household when the primary case was a parent or another member of the family.
  278. (1952). Tuberculosis induced by droplet nuclei infection: pulmonary tuberculosis of predetermined initial intensity in mammals.
  279. (1996). Tuberculosis of the genitourinary tract.
  280. (1972). Tuberculosis outbreak in a general hospital: evidence for airborne spread of infection.
  281. (2000). Tuberculosis: a comprehensive international approach.
  282. (2010). Tuberculosis: fact sheet
  283. (2004). Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infectious Diseases,
  284. (1992). Tuberculous meningitis in patients infected with the human immunodeficiency virus.
  285. (1995). Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.
  286. (2009). Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission.
  287. (2003). Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum.
  288. (2004). Use of genome level-informed PCR as a new investigational approach for analysis of outbreakassociated Mycobacterium tuberculosis isolates.
  289. (2003). Use of loop-mediated isothermal amplification of the IS900 sequence for rapid detection of cultured Mycobacterium avium subsp. paratuberculosis.
  290. (2005). Use of rapid genomic deletion typing to monitor a tuberculosis outbreak within an urban homeless population.
  291. (2003). Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis.
  292. (1996). Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis.
  293. (1997). Using a mathematical model to evaluate the efficacy of TB control measures. Emerging Infectious Diseases,
  294. (2003). Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates.
  295. (2006). Variable host-pathogen compatibility in Mycobacterium tuberculosis.
  296. (2000). Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome.
  297. (1997). Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression.
  298. (1998). Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New England
  299. (1995). Viral inactivation by potassium ferrate.
  300. (2007). Who puts the tubercle in tuberculosis?
  301. (2002). Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.